Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-GIPC1 (1-333) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:1000-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
GIPC1 |
Gene ID: |
10755 |
Uniprot ID: |
GIPC1_HUMAN |
Immunogen Region: |
1-333 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-333 of human GIPC1 (NP_005707.1). |
Immunogen Sequence: |
MPLGLGRRKKAPPLVENEEA EPGRGGLGVGEPGPLGGGGS GGPQMGLPPPPPALRPRLVF HTQLAHGSPTGRIEGFTNVK ELYGKIAEAFRLPTAEVMFC TLNTHKVDMDKLLGGQIGLE DFIFAHVKGQRKEVEVFKSE DALGLTITDNGAGYAFIKRI KEGSVIDHIHLISVGDMIEA INGQSLLGCRHYEVARLLKE LPRGRTFTLKLTEPRKAFDM ISQRSAGGRPGSGPQLGTG |
Tissue Specificity | Widely expressed. Expressed in skeletal muscle (at protein level). |
Function | May be involved in G protein-linked signaling. |
Protein Name | Pdz Domain-Containing Protein Gipc1Gaip C-Terminus-Interacting ProteinRgs-Gaip-Interacting ProteinRgs19-Interacting Protein 1SynectinTax Interaction Protein 2Tip-2 |
Cellular Localisation | CytoplasmMembranePeripheral Membrane Protein |
Alternative Antibody Names | Anti-Pdz Domain-Containing Protein Gipc1 antibodyAnti-Gaip C-Terminus-Interacting Protein antibodyAnti-Rgs-Gaip-Interacting Protein antibodyAnti-Rgs19-Interacting Protein 1 antibodyAnti-Synectin antibodyAnti-Tax Interaction Protein 2 antibodyAnti-Tip-2 antibodyAnti-GIPC1 antibodyAnti-C19orf3 antibodyAnti-GIPC antibodyAnti-RGS19IP1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance